Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Aytu Biopharma (AYTU) Non Operating Investment Income: 2016-2017

  • Aytu Biopharma's Non Operating Investment Income was N/A to $230,936 in Q2 2017 from the same period last year, while for Jun 2017 it was $169,417, marking a year-over-year change of. This contributed to the annual value of -$61,519 for FY2017, which is 93.67% up from last year.
  • Latest data reveals that Aytu Biopharma reported Non Operating Investment Income of $230,936 as of Q2 2017, which was up 178.96% from -$292,455 recorded in Q1 2017.
  • Over the past 5 years, Aytu Biopharma's Non Operating Investment Income peaked at $728,100 during Q3 2016, and registered a low of -$497,164 during Q4 2016.
  • Moreover, its 2-year median value for Non Operating Investment Income was -$30,760 (2017), whereas its average is $42,354.